Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1287 |
---|---|
Product Name | Anti-Human EGFL7 Recombinant Antibody |
Molecular Name | Parsatuzumab |
Alias | Anti-EGFL7 Recombinant Antibody, Research Grade Parsatuzumab |
CAS Number | 1312797-14-0 |
Target | EGFL7[Homo sapiens] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Host | Mouse |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | Block |
Buffer | PBS, pH7.5 |
Background | Parsatuzumab (INN) is a humanized monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to EGFL7. This drug was developed by Genentech/Roche. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |